Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 11/20 | 0.57 |
| ▸ | PIK3CD | O00329 | 6/20 | 0.57 |
| ▸ | MTOR | P42345 | 6/20 | 0.56 |
| ▸ | PDCD1 | Q15116 | 10/20 | 0.55 |
| ▸ | CD274 | Q9NZQ7 | 10/20 | 0.55 |
| ▸ | ATR | Q13535 | 9/20 | 0.55 |
| ▸ | CHEK1 | O14757 | 8/20 | 0.55 |
| ▸ | ATRIP | Q8WXE1 | 8/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3603549 | 0.91 | PIK3CA (0.57) | PIK3CAPIK3CDMTORPDCD1CD274 | |
| SCHEMBL739897 | 0.86 | PIK3CA (0.72) | PIK3CAPIK3CDMTORPDCD1CD274 | |
| SCHEMBL3593430 | 0.84 | PIK3CA (0.63) | PIK3CAPIK3CDMTORPDCD1CD274 | |
| SCHEMBL11924836 | 0.84 | PIK3CA (0.55) | PIK3CAPIK3CDMTORPDCD1CD274 | |
| SCHEMBL3594878 | 0.83 | PIK3CA (0.61) | PIK3CAPIK3CDMTORPDCD1CD274 | |
| SCHEMBL13283710 | 0.83 | PIK3CA (0.61) | PIK3CAPIK3CDMTORPDCD1CD274 | |
| SCHEMBL3605292 | 0.83 | PIK3CA (0.60) | PIK3CAPIK3CDMTORPDCD1CD274 | |
| SCHEMBL3588785 | 0.83 | PIK3CA (0.60) | PIK3CAPIK3CDMTORPDCD1CD274 | |
| SCHEMBL3596780 | 0.83 | PIK3CA (0.60) | PIK3CAPIK3CDMTORPDCD1CD274 | |
| SCHEMBL3602515 | 0.82 | PIK3CA (0.50) | PIK3CAPIK3CDMTORPDCD1CD274 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008023159-A1 | MORPHOLINO PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF PROLIFERATIVE DISORDERS | ASTRAZENECA AB (SE) | 2008-02-28 | — | — | WO | disclosed |